LSE:AZN (AstraZeneca PLC)
About AZN
AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
AstraZeneca PLC (LSE: AZN) Latest News
Investing Articles
1 cheap FTSE 100 share to buy in April
Investing Articles
1 of the best FTSE 100 shares to buy in a recession?
Investing Articles
Should investors buy the AstraZeneca share price dip?
Investing Articles
Best British shares to buy in March
Investing Articles
What would a £300 investment in AstraZeneca shares made 3 years ago be worth now?
Investing Articles
1 FTSE 100 share I’d put 100% of my money into
Investing Articles
3 cheap UK shares I’d buy to help protect my portfolio in a recession
Investing Articles
These three FTSE 100 stocks have huge upside
Investing Articles
Here’s the AstraZeneca dividend forecast for 2023
Investing Articles
Earnings: why AstraZeneca shares are climbing
Investing Articles
These were the FTSE 100’s biggest flops in January!